Cite

HARVARD Citation

    Cohen, S. et al. (2014). OP0154 Integrated Safety Analysis of Tofacitinib in RA Clinical Trials with A Cumulative Exposure of 12, 664 Patient-Years. Annals of the rheumatic diseases. pp. 119-120. [Online]. 
  
Back to record